7 High-Yield Dividend Value Stocks to Buy

von Tobias Borgers | Mai 21, 2020 | Abbvie

Dividend stocks provide a reliable income stream. While near-term fluctuations in the stock market can be unpredictable, dividends are one… Dividend stocks provide a reliable income stream. While near-term fluctuations in the stock market can be unpredictable,...

Published on: 19 May 2020 FDA approves Roche’s Tecentriq as a first-line monotherapy for certain people with metastatic non-small cell lung cancer

von Tobias Borgers | Mai 21, 2020 | Roche

FDA approves Roche’s Tecentriq as a first-line monotherapy for certain people with metastatic non-small cell lung cancer Tecentriq’s fourth indication in metastatic non-small cell lung cancer and fifth indication in lung cancer overall in the US  Approval based on the...

Coronavirus tracker: GSK teams up for CRISPR diagnostic; AstraZeneca nabs $1B-plus grant; CanSino adds mRNA efforts

von Tobias Borgers | Mai 21, 2020 | Glaxo

AstraZeneca has secured over $1 billion from the HHS‘ Biomedical Advanced Research and Development Authority (BARDA) to develop and supply its Oxford University-partnered vaccine. China’s CanSino Biologics, already the development frontrunner with a...

Equine Healthcare Market 2020: Potential Growth, Challenges, and Know the Companies List Could Potentially Benefit or Loose out From the Impact of COVID-19 | Key Players: Affymetrix, Bayer Health Care, Boehringer Ingelheim, Elanco Animal Health, Merck Animal Health, etc.

von Tobias Borgers | Mai 21, 2020 | Boehringer

InForGrowth Market Research offers a most recent distributed report on Global Equine Healthcare industry examination and figure 2019-2025 conveying key bits of knowledge and giving an upper hand to customers through a point by point report. The report contains XX...

Standortleiterwechsel bei Bayer in Wuppertal

von Tobias Borgers | Mai 15, 2020 | Bayer

Wuppertal, 14. Mai 2020 – Am 1. Mai hat Dr. Timo Fleßner (49) die Leitung des Bayer-Standorts Wuppertal übernommen. Er folgt auf Dr. Holger Weintritt (50), der sich nach zweijähriger Standortleitung nun komplett auf seine Aufgaben als global verantwortlicher Leiter...

Bayer und Nuvisan schaffen neue Forschungseinheit in Berlin

von Tobias Borgers | Feb 11, 2020 | Bayer

Berlin, 11. Februar 2020 – Bayer hat mit Nuvisan die Übernahme eines großen Teils seiner in Berlin ansässigen Forschung auf dem Gebiet kleinmolekularer Wirkstoffe vereinbart. Die Nuvisan Gruppe ist ein internationaler Dienstleister im Bereich der klinischen Studien,...